Publication
Low carbon projects
Low carbon projects, especially those involving hydrogen and Carbon Capture and Storage (CCS), play a crucial role in the journey towards global decarbonisation.
United States | Publication | February 14, 2022
The US Securities and Exchange Commission (SEC) took another step closer this week towards its aim to provide greater oversight of private funds. On February 9, 2022, the SEC approved and passed, by a three to one vote, a proposal requiring private equity and hedge funds to provide basic disclosures to their investors and guard against conflicts. This proposal comes less than a month after the SEC announced proposed disclosure rules aimed at obtaining more information from private equity and hedge funds to help regulators better spot risks in private markets, which we discussed in this previous legal update.
If approved, these proposed disclosures would not have to be filed with the SEC or made public. Instead, private funds would generally be required to maintain books and records to allow regulators to assess their compliance with the rules. Additionally, the proposal identifies and prohibits a myriad of activities related to private funds with the aim of addressing what the SEC perceives as a "lack of governance mechanisms" by private fund advisers. Under the proposal:
The proposed amendments will be open for comment for 60 days following publication of the proposing release on the SEC’s website or 30 days following publication of the proposing release in the Federal Register, whichever period is later.
Special thanks to Emma Yeremou-Ngah for her assistance in the preparation of this content.
Publication
Low carbon projects, especially those involving hydrogen and Carbon Capture and Storage (CCS), play a crucial role in the journey towards global decarbonisation.
Publication
Taking your company public is an important milestone, and whilst the landscape for IPOs is complex and dynamic, choosing the right path is essential.
Publication
The budget reconciliation bill (P.L. 119-21), known as the “One Big Beautiful Bill,” marks a fundamental and far-reaching overhaul of the US healthcare system, ushering in the most significant retractions and changes since the Affordable Care Act in 2010.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright US LLP 2025